Transitional Cell Carcinoma of the Urinary Tract

Slides:



Advertisements
Similar presentations
Thyroid Cancer -- Papillary
Advertisements

Urothelial CA: Cancers of the Bladder, Ureter, and Renal Pelvis
Advances in the Diagnosis and Management of Bladder Cancer Mr C Dawson MS FRCS Consultant Urologist Edith Cavell Hospital Peterborough.
Cancer of Unknown Primary
Dr Manish Patel MB.BS., MMed., FRACS Urological Oncologist
The Role of Urine cytology in the investigation of Haematuria? B Barrass Audit Meeting 17 th May 2006.
Cases in Urological Oncology Dr Manish Patel MB.BS., MMed., FRACS, PhD Urological Cancer Surgeon Westmead Public and Private Hospital Westmead Public and.
Urostomy Why? Patricia Anderson BSN RN CWOCN. The American Cancer Society’s estimates for bladder cancer in the United States for 2013 are: About 72,570.
Haematuria and Urinary Tract Tumours
Bladder tumors 3 times more common in men
Endoscopic diagnosis of upper-tract TCC – Correlating indications, investigations and histology Finch W, Shah N, Wiseman O Addenbrooke’s Hospital Cambridge.
Bladder Cancer R. Zenhäusern. Bladder cancer: Epidemiology Incidence:20/100000/year (Europe) Mortality:8-9/100000/year Fourth most common cancer in men.
LOGO UPPER URINARY TRACT T.C.C. Presented by: Dr.HashimNaji R3.
Dr. Abdelaty Shawky Dr. Gehan Mohamed
 Cervical cancer is a malignant tumour deriving from cells of the "cervix uteri", which is the lower part of uterus.  Begins in the lining of the cervix.
Colorectal cancer Khayal AlKhayal MD,FRCSC
BLADDER CANCER. Incidence Fourth most common cancer in men Ninth most common cancer in women Sustained decline in incidence over recent times 60 % reduction.
Treatment Localized disease: Radical nephrectomy. Metstatic disease: Radiation therapy. Immunotherapy PROGNOSIS: stage % 5yrs survival stageII 60%
Bladder Carcinomas. Incidence Risk factors Staging Histopathology – Papilloma – Transitional Cell Carcinoma – Nontransitional Cell Carcinoma Adenocarcinoma.
Cervical Cancer. Cervix Lower part of the uterus Lower part of the uterus Connects the body of the uterus to the vagina (birth canal) Connects the body.
Electronic Image Safe (Remove for final output). BCG Plus IFN-  Combination Therapy Rationale Evidence of synergistic activity Evidence of synergistic.
Hematuria and Related Urologic Oncology
Surgical Management of Urothelial Carcinoma A 21 st Century Approach Douglas S. Scherr, M.D. Clinical Director, Urologic Oncology Weill Medical College.
Adult Medical-Surgical Nursing
PRESENTING LUNG CANCER. Lung Cancer: Defined  Uncontrolled growth of malignant cells in one or both lungs and tracheo-bronchial tree  A result of repeated.
In the name of God Isfahan medical school Shahnaz Aram MD.
LUNG CANCER Dr.Mohammadzadeh. Lung cancer is the leading cancer killer in the United States. Every year, it accounts for 30% of all cancer deaths— more.
Current Role of Partial Cystectomy: Are we scarifying patient ’ s survival Dr Eric Li Department of Surgery Pamela Youde Nethersole hospital.
1 CANCER OF THE BLADDER. 2  Cancer of the bladder is the second most common urologic malignancy.  90% of all bladder cancers are transitional cell carcinomas,
Dr. Abdellatif Zayed Bladder Cancer.
HEMATURIA Danger Signal that can’t be ignored. 1. Duration of symptoms and are they painful? 2.Presence of symptoms of an irritated bladder 3.What portion.
Management of T1G3 Bladder cancer Dr Charles Chabert.
Renal tumours Dr. Hawre Qadir Salih.
Bladder cancer is the second most common cancer of the genitourinary tract. The incidence is higher in whites than in African Americans. The average age.
Neoplasms of the bladder
Contemporary Treatment Guidelines on Bladder Cancer
COSULTANT UROLOGIST.  Diseases of lower urinary tract.
Urinary Tract System Bladder Cancer.
Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis? Yair Lotan, Robert S. Svatek, Arthur I. Sagalowsky.
Suspected Malignancy B 陳建佑. Symptoms Red Urinary Hesitance Urination.
BREAST CANCER Oncology
Cancer - renal pelvis or ureter. Overview Cancer of the renal pelvis or ureter is cancer that forms in the pelvis or the tube that carries urine from.
Bladder tumor dr,mohamed fawzi alshahwani 1. facts Bladder cancer is the second most common cancer of the genitourinary tract.Bladder cancer is the second.
By Dr. Abdelaty Shawky Assistant professor of pathology
Urological Cancer Kieran Jefferson Consultant Urological Surgeon
Hassan Farsi, Anmar Nassir, Hesham Saada, Rami Salawi.
Invasive cervical cancer. Background Most common cancer of women in Africa, most common gynaecologic cancer, most common cancer of black and coloured.
Kidney cancer Bladder cancer Hanjong Park, PhD, RN.
RENAL PARENCHYMA NEOPLASM ADENOCARCINOMA (RENAL CELL CARCINOMA). Adenocarcinoma of kidney represent about 3% of adult cancer Adenocarcinoma of kidney.
Trends in bladder cancer treatments
أورام المثانة Bladder cancer Dr.Alseoudi Alhadi د.الهادي السعودي Albairouni C.H.U.
Carcinoma of Bladder & Prostate BPH
Bladder Cancer Mark Browning, M.D. ‘ IUSME.
Carcinoma of the prostate. INTRODUCTION Prostate cancer is the most common cancer diagnosed and is the second leading cause of cancer death in men in.
Urothelial tumors Tumors in the collecting system above the bladder are relatively uncommon. These tumors are classified into : 1 benign papilloma. 2-papillary.
Kidney Cancer – All You Need to Know!
Evaluation of renal masses
Carcinoma of the urinary bladder in a tertiary care setting in a developing country Farhana Badar, Ambreen Sattar, Fouzia Meerza, Noreen Irfan, Neelam.
Case 3 75 Yr male. pT1 TCC upper ureter. Smoker CKD stage 2 Diabetic Monday morning. Patient admitted for lap nephroureterectomy. Discuss procedure and.
Canadian Undergraduate Urology Curriculum (CanUUC): Hematuria
Bladder Cancer R. Zenhäusern.
The Uganda Cancer Institute Experience Walusansa Victoria.
Haematuria Haematuria is a common condition and one which must be taken seriously. Haernaturia is usually divided into :- - Macroscopic (where the urine.
URO ONCOLOGY BLADDER CANCER DONE BY: SHATHA MUQBIL SHAMS KADHIM.
Endoscopic Treatment of Upper Tract Urothelial Tumours
Management of Invasive Bladder Cancer
Urinary bladder cancer
Presentation transcript:

Transitional Cell Carcinoma of the Urinary Tract Manish Patel Urology Registrar Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract

Epidemiology Men >women Incidence increasing in men Mortality decreasing Age- middle aged and elderly Race- blacks > whites All symptomatic before death Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract

Etiology Smoking Occupational exposure Analgesic abuse Cyclophosphamide ?heredity Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract

Pathology Carcinoma insitu Superficial invasive Low grade Mod grade High Grade Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract

Natural History 75% superficial at presentation 2/3 well-mod diff.- 0nly 10% become invasive or metastastic 1/3 high grade-50% become invasive 25% invasive- most are high grade CIS- 16% become invasive Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract

Natural History 40% muscle invasive TCC have occult distant mets Nearly all Pts with mets die within 2 years Spread Lymphnodes, Liver, Lung, Bone, Adrenal Local Complications Bleeding, Pain, Ureteral Obstruction, Local invasion surrounding structures/fistula. Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract

Diagnosis Microurine, urine cytology IVP, U/S, CT Cystoscopy and biopsy Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract

Staging Biopsy CT abdomen and pelvis CXR Bone scan Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract

Management superficial bladder TCC Transurethral resection or fulgration 70% 5 year survival 10% will ultimately require more aggressive Treatment Lamina Propria invasion has 46% muscle invasion later multiple or recurrent TCC will respond to intravesical chemo or BCG Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract

Management of Muscle Invasive TCC Bladder TURBT Partial Cystectomy DXRT with cystectomy salvage 35% 5 year survival 50-70% bladder recurence at 5 years 10% severe persistent complications Only 8-15% are suitable for salvage cystectomy- 40% 5 year survival Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract

Management of Muscle Invasive TCC Bladder Radical Cystectomy Most effective form of cure 70% 5 year survival 45% 5 year survival outside bladder Complications-25% infection, intestinal obstruction, hemorrage, DVT, urine or faecal leak Mortality-1% Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract

Adjuvant chemotherapy Radical cystectomy Ileal conduit Neobladder Continent urinary diversions ureterosigmoidostomy Adjuvant chemotherapy Sig survival advantage for tumour outside bladder and minor nodal involvement. Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract

Metastatic TCC 4 drug regimen MVAC used improves median survival from 8 months to 12 months. 6% mortality rate from toxicity Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract

TCC of renal pelvis and ureter 10% or renal tumours, 5% of TCC Same risk factors as bladder TCC 30%-75% also have bladder TCC at some stage Ureteral tumours more common at lower end Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract

TCC upper tract-symptoms & signs Haematuria, pain, metastatic disease, incidental Diagnosis IVP C/E RGP cytology and brushings CT U/S Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract

Most tumours are low stage, low grade Treatment Nephroureterectomy Staging Similar to bladder Most tumours are low stage, low grade Treatment Nephroureterectomy 91% 5 years survival-superficial 43% 5 year survival -muscle invasive 0-23% advanced disease Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract

Treatment Conservative excision Only low grade +stage and renal disease Endoscopic Treatment Ureteroscope with laser or fulgration Again only for low grade+stage/ renal disease. Major medical illness Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract

Carcinoma in-situ No symptoms to frequency and dysuria C/E normal or velvety erythema High grade, 25% of HG TCC will have it Often detected on urine cytology >20% risk of developing invasive TCC or already harbouring it. Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract

Carcinoma in-situ Best treatment is intravesical BCG Can also give other cytotoxic eg. Mitomycin Water Works By The Waves Transitional Cell Carcinoma of the Urinary Tract